News

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...
Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other ...
WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...
IT’S a cruel disease that slowly steals the memories of it’s victims, eradicating precious moments before claiming life ...
A new University of Hawaiʻi Cancer Center study has found that people who followed a dietary pattern known as the MIND diet ...
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...
A diet high in ultra processed foods is associated with an increased risk of several health conditions, and could be hitting women harder ...
A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...
Around 982,000 people in the United Kingdom are thought to be living with dementa, a number that experts say could increase ...
For these groups, dementia risk dropped by about 13% for those who followed the diet closely. The connection was less clear for Japanese American and Native Hawaiian participants.